Smartkarma's AI Co-Pilot, Smartkarma

αSK

Smartkarma's AI Co-Pilot

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
 <li>PolyNovo is a rapidly growing medical device company whose patented NovoSorb® biodegradable polymer technology is disrupting the advanced wound care market, particularly in burns and trauma.</li>
 <li>The company has demonstrated exceptional revenue growth, recently achieving profitability, driven by the increasing adoption of its flagship product, NovoSorb BTM, in key markets like the United States.</li>
 <li>Future growth is expected to be fueled by geographic expansion into new markets, the launch of new products and indications (such as NovoSorb MTX), and potential tailwinds from favorable reimbursement changes in the U.S.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  PolyNovo is a rapidly growing medical device company whose patented NovoSorb® biodegradable polymer technology is disrupting the advanced wound care market, particularly in burns and trauma.
  The company has demonstrated exceptional revenue growth, recently achieving profitability, driven by the increasing adoption of its flagship product, NovoSorb BTM, in key markets like the United States.
  Future growth is expected to be fueled by geographic expansion into new markets, the launch of new products and indications (such as NovoSorb MTX), and potential tailwinds from favorable reimbursement changes in the U.S.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Global Healthcare Analyst

Tina Banerjee

<ul>
<li>
<a href="https://www.smartkarma.com/entities/polynovo-ltd" target="_blank" data-smartkarma-citation="entities:12208:1" rel="noopener">PolyNovo Ltd (PNV AU)</a> reported 29% YoY growth in FY25 revenue to A$119M, driven by 29% YoY growth in U.S. sales to A$88M. RoW sales grew 30% YoY to AS$30M.</li>
<li>PolyNovo expects continued sales growth as multiple products received relevant regulatory clearance. Leveraging on proven track record in full thickness burn procedures, PolyNovo is driving adoption in additional surgical areas.</li>
<li>Strong FY25 result enhances conviction on the growth prospects. Broader rollout of NovoSorb MTX across multiple regions and increasing demand from plastic and reconstructive procedures are expected drive growth.</li>
</ul>



PolyNovo Ltd (PNV AU) reported 29% YoY growth in FY25 revenue to A$119M, driven by 29% YoY growth in U.S. sales to A$88M. RoW sales grew 30% YoY to AS$30M.
PolyNovo expects continued sales growth as multiple products received relevant regulatory clearance. Leveraging on proven track record in full thickness burn procedures, PolyNovo is driving adoption in additional surgical areas.
Strong FY25 result enhances conviction on the growth prospects. Broader rollout of NovoSorb MTX across multiple regions and increasing demand from plastic and reconstructive procedures are expected drive growth.


PolyNovo (PNV AU): Solid FY25 Performance; Label and Geography Expansion to Accelerate Growth

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Australia's ASIC releases the aggregated short position data four business days after the reporting day. Data in this insight is up to 25th May, published on the 29th May.</li>
<li>The largest industry net increase in the past week was A$486mn into "Diversified Banks"; the largest industry net decrease was A$239mn out of "Interactive Media". Net shorts increased A$0.8bn week-on-week.</li>
<li>Companies mentioned in this regular weekly report include: <a href="https://www.smartkarma.com/entities/pls-group-limited" target="_blank" data-smartkarma-citation="entities:7460:1" rel="noopener">PLS (PLS AU)</a>, <a href="https://www.smartkarma.com/entities/newmont-corp" target="_blank" data-smartkarma-citation="entities:40416:1" rel="noopener">Newmont (NEM AU)</a>, <a href="https://www.smartkarma.com/entities/suncorp-group-ltd" target="_blank" data-smartkarma-citation="entities:4218:1" rel="noopener">Suncorp (SUN AU)</a>, <a href="https://www.smartkarma.com/entities/transurban-group" target="_blank" data-smartkarma-citation="entities:593:1" rel="noopener">Transurban (TCL AU)</a>, <a href="https://www.smartkarma.com/entities/capstone-copper-corp-6eb66be6-7a3f-4b9c-9c73-dbc2c4df321f" target="_blank" data-smartkarma-citation="entities:44139:1" rel="noopener">Capstone Copper (CSC AU)</a>, <a href="https://www.smartkarma.com/entities/lendlease-group" target="_blank" data-smartkarma-citation="entities:11248:1" rel="noopener">Lendlease (LLC AU)</a>, <a href="https://www.smartkarma.com/entities/block-inc" target="_blank" data-smartkarma-citation="entities:35684:1" rel="noopener">Block (SQ2 AU)</a>.</li>
</ul>


Australia's ASIC releases the aggregated short position data four business days after the reporting day. Data in this insight is up to 25th May, published on the 29th May.
The largest industry net increase in the past week was A$486mn into "Diversified Banks"; the largest industry net decrease was A$239mn out of "Interactive Media". Net shorts increased A$0.8bn week-on-week.
Companies mentioned in this regular weekly report include: PLS (PLS AU), Newmont (NEM AU), Suncorp (SUN AU), Transurban (TCL AU), Capstone Copper (CSC AU), Lendlease (LLC AU), Block (SQ2 AU).


Aussie Shorts [25 May]: PLS, Newmont, Suncorp, Transurban, Capstone Copper, Lendlease, Block

Asia Pac ECM and Index Rebal, DZT Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of ASX Stocks as of May 22nd (reported today). The aggregated short interest was USD44.0bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Suncorp, BHP, Computershare, Northern Star Resources, Wesfarmers.</li>
</ul>


We analyzed the changes in short interest of ASX Stocks as of May 22nd (reported today). The aggregated short interest was USD44.0bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Suncorp, BHP, Computershare, Northern Star Resources, Wesfarmers.


ASX Short Interest Weekly (May 22nd): Suncorp, BHP, Computershare, Northern Star Resources

<ul>
<li>Australia's ASIC releases the aggregated short position data four business days after the reporting day. Data in this insight is up to 18th May, published on the 22nd May.</li>
<li>The largest industry net increase in the past week was just A$49mn into "Industrial REITs"; the largest net decrease was A$531mn out of "Diversified Banks". Net shorts fell A$1.6bn week-on-week.</li>
<li>Companies mentioned in this regular weekly report include: <a href="https://www.smartkarma.com/entities/insurance-australia-group-ltd" target="_blank" data-smartkarma-citation="entities:712:1" rel="noopener">Insurance Australia (IAG AU)</a>, <a href="https://www.smartkarma.com/entities/4dmedical-ltd" target="_blank" data-smartkarma-citation="entities:30789:1" rel="noopener">4DMedical (4DX AU)</a>, <a href="https://www.smartkarma.com/entities/the-lottery-corp-ltd" target="_blank" data-smartkarma-citation="entities:35970:1" rel="noopener">The Lottery Corporation (TLC AU)</a>, <a href="https://www.smartkarma.com/entities/national-australia-bank-ltd" target="_blank" data-smartkarma-citation="entities:15:1" rel="noopener">NAB (NAB AU)</a>, <a href="https://www.smartkarma.com/entities/anz-group-holdings-ltd" target="_blank" data-smartkarma-citation="entities:40898:1" rel="noopener">ANZ  (ANZ AU)</a>, and <a href="https://www.smartkarma.com/entities/westpac-banking-corp" target="_blank" data-smartkarma-citation="entities:444:1" rel="noopener">Westpac (WBC AU)</a>.</li>
</ul>


Australia's ASIC releases the aggregated short position data four business days after the reporting day. Data in this insight is up to 18th May, published on the 22nd May.
The largest industry net increase in the past week was just A$49mn into "Industrial REITs"; the largest net decrease was A$531mn out of "Diversified Banks". Net shorts fell A$1.6bn week-on-week.
Companies mentioned in this regular weekly report include: Insurance Australia (IAG AU), 4DMedical (4DX AU), The Lottery Corporation (TLC AU), NAB (NAB AU), ANZ  (ANZ AU), and Westpac (WBC AU).


Aussie Shorts [18th May]: Insurance Australia, 4DMedical, The Lottery Corp., NAB, ANZ, and Westpac

Australia

PolyNovo Limited is a biotechnology company. The Company has a portfolio of biodegradeable polymers that have potential for application across numerous medical fields.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

PolyNovo Ltd (PNV AU)

Primer: PolyNovo Ltd (PNV AU) - Oct 2025

PolyNovo is a rapidly growing medical device company whose patented NovoSorb® biodegradable polymer technology is disrupting the advanced wound...

αSK

PolyNovo (PNV AU): Solid FY25 Performance; Label and Geography Expansion to Accelerate Growth

PolyNovo reported strong FY25 revenue growth of 29% YoY driven by U.S. sales. The company expects continued growth with new product clearances and...

Tina Banerjee

Aussie Shorts [25 May]: PLS, Newmont, Suncorp, Transurban, Capstone Copper, Lendlease, Block

Companies mentioned in this regular weekly report include: PLS (PLS AU), Newmont (NEM AU), Suncorp (SUN AU), Transurban (TCL AU), Capstone Copper...

David Blennerhassett

ASX Short Interest Weekly (May 22nd): Suncorp, BHP, Computershare, Northern Star Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in Suncorp, BHP, Computershare, Northern Star...

Ke Yan, CFA, FRM

Aussie Shorts [18th May]: Insurance Australia, 4DMedical, The Lottery Corp., NAB, ANZ, and Westpac

Net shorts fell A$1.6bn week-on-week. Companies mentioned in this regular weekly report include: Insurance Australia, 4DMedical, The Lottery...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Primer: PolyNovo Ltd (PNV AU) - Oct 2025

PolyNovo is a rapidly growing medical device company whose patented NovoSorb® biodegradable polymer technology is disrupting the advanced wound...

αSK

PolyNovo (PNV AU): Solid FY25 Performance; Label and Geography Expansion to Accelerate Growth

​PolyNovo reported strong FY25 revenue growth of 29% YoY driven by U.S. sales. The company expects continued growth with new product clearances and...

Tina Banerjee

Aussie Shorts [25 May]: PLS, Newmont, Suncorp, Transurban, Capstone Copper, Lendlease, Block

Companies mentioned in this regular weekly report include: PLS (PLS AU), Newmont (NEM AU), Suncorp (SUN AU), Transurban (TCL AU), Capstone Copper...

David Blennerhassett

ASX Short Interest Weekly (May 22nd): Suncorp, BHP, Computershare, Northern Star Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in Suncorp, BHP, Computershare, Northern Star...

Ke Yan, CFA, FRM

Aussie Shorts [18th May]: Insurance Australia, 4DMedical, The Lottery Corp., NAB, ANZ, and Westpac

Net shorts fell A$1.6bn week-on-week. Companies mentioned in this regular weekly report include: Insurance Australia, 4DMedical, The Lottery...

David Blennerhassett

PolyNovo reported strong FY25 revenue growth of 29% YoY driven by U.S. sales. The company expects continued growth with new product clearances and...